Home Compare ABBV vs ORNBV.HE
Stock Comparison · Industry comparison · Drug Manufacturers - General

AbbVie vs Orion Oyj: Which Stock Looks Stronger in 2026?

Orion Oyj holds the cleaner structural position, with the lead spread across profitability and valuation. AbbVie does not offset that deficit through any equally strong structural edge elsewhere. On the market side, Orion Oyj is in better shape — its trend is intact while AbbVie's trend has broken down. That puts structure and market broadly in agreement — Orion Oyj's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across profitability and valuation, rather than sitting in one isolated gap. The overall score gap is 39 points in favour of Orion Oyj.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. ABBV and ORNBV.HE share the same industry classification.

For a similarity-based comparison, see how AbbVie and Orion Oyj each position within their functional peer groups in AssetNext.

Peer-Relative Score
ABBV
AbbVie Inc.
44
Peer-Score
Signal qualityHigh
vs
ORNBV.HE
Orion Oyj
83
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: ABBV vs ORNBV.HE Profitability 40 100 Stability 68 71 Valuation 19 61 Growth 62 100 ABBV ORNBV.HE
Gap Ranking
#1 Profitability +60
#2 Valuation +42
#3 Growth +38
#4 Stability +3
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for ABBV and ORNBV.HE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer ABBVORNBV.HE Relative valuation Structural strength

Orion Oyj looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Both profiles are strong on profitability, but Orion Oyj leads clearly.
Valuation
On valuation, Orion Oyj is positioned higher in the group, while AbbVie Inc. is closer to the middle.
Profitability — Dominant Gap
ABBV
40
ORNBV.HE
100
Gap+60in favour of ORNBV.HE

The profitability lead is mainly driven by a 13.1-point operating margin advantage.

What keeps the gap from being one-sided

Stability is the one area where AbbVie Inc. still pushes back materially — it is the steadier name on this dimension, which keeps the result from reading as one-way.

What this means for the comparison

The lead is built on both profitability and valuation, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the ABBV vs ORNBV.HE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-valuation comparisons

Explore how ABBV and ORNBV.HE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.